Category: Press Release - Page 158 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article After Delay DC’s Initiative 81 Now Under Mandated 30-Day Congressional Review

After Delay DC’s Initiative 81 Now Under Mandated 30-Day Congressional Review

Post published:February 3, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Mydecine Innovations Group Appoints Josephine Wu to Board of Directors

Post published:February 3, 2021
Post category:Press Release

Read more about the article COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy

COMPASS Pathways announces publication in Frontiers in Psychiatry of paper on therapist training programme for psilocybin therapy

Post published:February 3, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Announces Appointment of Greg McKee as Executive Chairman

Tryp Therapeutics Announces Appointment of Greg McKee as Executive Chairman

Post published:February 3, 2021
Post category:Press Release

Read more about the article Red Light Holland Announces Increase in Bought Deal Equity Financing to $10 Million

Red Light Holland Announces Increase in Bought Deal Equity Financing to $10 Million

Post published:February 3, 2021
Post category:Press Release

Read more about the article Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Havn Life Announces Strategic Clinical Trial Partnership with HealthTech Connex Inc.

Post published:February 2, 2021
Post category:Press Release

Read more about the article BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder

Post published:February 2, 2021
Post category:Press Release

Read more about the article PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.

PharmaDrug Completes Acquisition of Sairiyo Therapeutics Inc.

Post published:February 2, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments

Post published:February 2, 2021
Post category:Press Release

Read more about the article MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics

MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics

Post published:February 2, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.